Kanjanasuntree Rungravee

Title: Kanjanasuntree Rungravee: Innovator in Inflammatory Disease Treatment

Introduction

Kanjanasuntree Rungravee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals and compositions aimed at treating inflammatory diseases. His innovative work has led to the development of a unique strain that holds promise for various applications.

Latest Patents

Kanjanasuntree Rungravee holds a patent for CAU Y1706 and a composition using the same. This invention relates to a novel strain, specifically CAU Y1706 (Accession No.: KCTC13794BP), which is utilized in pharmaceutical, food, cosmetic, and probiotic compositions. These compositions are designed to prevent or treat inflammatory diseases, showcasing the potential of his research in improving health outcomes.

Career Highlights

He is affiliated with Chung Ang University Industry Academic Cooperation, where he continues to advance his research and innovation. His work is characterized by a commitment to developing effective solutions for health-related challenges.

Collaborations

Kanjanasuntree Rungravee collaborates with esteemed colleagues, including Won Yong Kim and Jong Hwa Kim. Their combined expertise enhances the research and development efforts within their institution.

Conclusion

Kanjanasuntree Rungravee's contributions to the field of inflammatory disease treatment through his innovative patent demonstrate his dedication to advancing medical science. His work at Chung Ang University Industry Academic Cooperation continues to pave the way for future breakthroughs in health and wellness.